. Our novel classification was derived using a similar modified Delphi process, and its intra-class correlation coefficient was measured at 0.88. Rosenthal et al. acknowledged the clear need to validate their suggested classification. In comparison, we have already validated our classification by testing the correlation between the severity of iAEs and 30-day postoperative outcomes, and demonstrated that iAEs with severity class C3 were correlated with worse 30-day morbidity and mortality. In addition, we have since described the nature, patterns, predictors, and clinical/financial outcomes of iAEs in several published or in press manuscripts, and presented our results in national and international meetings [3] [4] [5] [6] [7] . In summary, we would like to emphasize three points: First, a novel classification of intraoperative adverse events has been published by our group at the Massachusetts General Hospital and Harvard Medical School. Second, this classification has been validated and is currently being validated further on an even greater scale. Third, we are currently conducting and planning additional research in this area and would welcome the collaboration of interested groups, like Rosenthal et al.'s, in order to create a sum outcome that is bigger than its parts.
